Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. Annals of the rheumatic diseases. 2018;77(9):1276-82.

28/02/2022

Lauper K, Nordström DC, Pavelka K, Hernández MV, Kvien TK, Kristianslund EK, et al.

Epub 2018/05/08. doi: 10.1136/annrheumdis-2017-212845. PubMed PMID: 29730637.